Page last updated: 2024-08-24

naphthalimides and Carcinoma, Ductal, Pancreatic

naphthalimides has been researched along with Carcinoma, Ductal, Pancreatic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cheng, WP; Cordeiro-da-Silva, A; Hoskins, C; Kong Thoo Lin, P; Lima, SC; Lombardo, D; Loureirio, I; Mas, E; Ouaissi, A; Ouaissi, M	1

Other Studies

1 other study(ies) available for naphthalimides and Carcinoma, Ductal, Pancreatic

Article	Year
In vitro and in vivo anticancer activity of a novel nano-sized formulation based on self-assembling polymers against pancreatic cancer. Pharmaceutical research, 2010, Volume: 27, Issue:12 Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Drug Screening Assays, Antitumor; Flow Cytometry; Humans; In Vitro Techniques; Inhibitory Concentration 50; Mice; Nanotechnology; Naphthalimides; Pancreatic Neoplasms; Polymers; Xenograft Model Antitumor Assays	2010

Article

Year

In vitro and in vivo anticancer activity of a novel nano-sized formulation based on self-assembling polymers against pancreatic cancer.

Pharmaceutical research, 2010, Volume: 27, Issue:12

Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Drug Screening Assays, Antitumor; Flow Cytometry; Humans; In Vitro Techniques; Inhibitory Concentration 50; Mice; Nanotechnology; Naphthalimides; Pancreatic Neoplasms; Polymers; Xenograft Model Antitumor Assays

2010